Erisyon is transforming the field of proteomics with the world’s first single molecule protein sequencer. With unprecedented sensitivity and scalability for proteomics, Erisyon enables new applications across the Life Sciences Erisyon has emerged from the University of Texas at Austin to commercialize the world’s first single molecule protein sequencer. Inheriting work developed over the course of the past decade at UT’s Center for Systems and Synthetic Biology, Erisyon was founded by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.
| Website | http://erisyon.com/ |
| Employees | 7 (3 on RocketReach) |
| Founded | 2018 |
| Address | 360 Nueces St, Austin, Texas, US |
| Technologies |
HTML
,
G Suite
,
Gmail
+2 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Discovery Tools (Healthcare) |
| Keywords | Protein Sequencing, Proteomics, Life Sciences, Protein Analysis, Biotechnology, Molecular Biology, Genomics, Biomedical Research, Drug Discovery, Biopharma, Next Generation Sequencing, Protein Characterization, Molecular Diagnostics, Biotechnology Tools, Proteomic Analysis, Protein Biomarkers, Clinical Proteomics |
| Competitors | Siemens, Dassault Systèmes, Cadence Design Systems, Autodesk, PTC, Altair, ANSYS Apache, COMSOL, Inc., DELMIAWorks +46 more (view full list) |
Looking for a particular Erisyon employee's phone or email?
Erisyon Questions
Jagannath Swaminathan is the Co-Founder and Chief Technology Officer of Erisyon.
3 people are employed at Erisyon.
Erisyon is based in Austin, Texas.
Top Erisyon Employees
-
42
-
44
-
24
Related Companies
